BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
| Browse: 414 | Download: 571
|
Received |
|
2013-12-12 17:30 |
|
Peer-Review Started |
|
2013-12-13 08:57 |
|
To Make the First Decision |
|
2014-02-27 09:30 |
|
Return for Revision |
|
2014-03-06 09:52 |
|
Revised |
|
2014-04-24 09:47 |
|
Second Decision |
|
2014-06-03 16:19 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2014-06-03 16:33 |
|
Articles in Press |
|
2014-06-03 16:49 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2014-08-01 15:04 |
|
Publish the Manuscript Online |
|
2014-09-04 09:25 |
Category |
Pharmacology & Pharmacy |
Manuscript Type |
Review |
Article Title |
Pharmacological therapy of feed intolerance in the critically ills
|
Manuscript Source |
Invited Manuscript |
All Author List |
Nam Q Nguyen |
Funding Agency and Grant Number |
|
Corresponding Author |
Nam Q Nguyen, Associate Professor, Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, North Terrace, Adelaide, 5000 South Australia, Australia. quoc.nguyen@health.sa.gov.au
|
Key Words |
Adverse effects; Critical illness; Enteral feeding; Feed intolerance; Prokinetic therapy |
Core Tip |
Feed intolerance during critical illness must be promptly recognized and treated due to the associated morbidity and mortality. The current first line treatment for feed intolerance is prokinetic therapy with erythromycin and metoclopramide (alone or in combination), which are highly effective and free of significant adverse effects. Although diarrhoea occurs commonly after combination prokinetic therapy, it is not associated with Clostridium difficile colitis and settled shortly after stopping the treatment. The use of prokinetic therapy over a long period or for prophylactic purpose, therefore, must be avoided and the indication for ongoing use of the drug(s) should be frequently reviewed.
|
Publish Date |
2014-09-04 09:25 |
Citation |
Nguyen NQ. Pharmacological therapy of feed intolerance in the critically ills. World J Gastrointest Pharmacol Ther 2014; 5(3): 148-155 |
URL |
http://www.wjgnet.com/2150-5349/full/v5/i3/148.htm |
DOI |
http://dx.doi.org/10.4292/wjgpt.v5.i3.148 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345